Advertisement

Topics

Latest "Laureate Pharma, Inc." News Stories

06:59 EDT 25th April 2018 | BioPortfolio

Here are the most relevant search results for "Laureate Pharma, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Laureate Pharma, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Laureate Pharma, Inc. for you to read. Along with our medical data and news we also list Laureate Pharma, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Laureate Pharma, Inc. Companies for you to search.

Showing "Laureate Pharma" News Articles 1–25 of 6,300+

Wednesday 25th April 2018

Pharma cos continue to release pollutants into common drains, PCB cracks whip and issues closure notice against violators

In spite of regular counseling, advisories and reminders to the members of pharma and bulk drug manufacturing companies on the significance of protecting the environment and highlighting about the need for abiding


Fidia Announces Presentation of New Data Evaluating HYMOVIS® Effects on Cartilage Volume and Type II Collagen Turnover at Osteoarthritis Research Society International (OARSI) World Congress Meeting

Poster Title: “Hyaluronan Derivative Hymovis® Increases Cartilage Volume and Type II Collagen Turnover in Osteoarthritis Knee: Data from MOKHA (MRI, BiOmarkers, Knee, Hymovis®, OsteoArthritis) Study” Fidia Farmaceutici, a world leader in the research, development and manufacturing of hyaluronic acid (HA)-based products and its wholly ...

MaxCyte appoints Infinity Pharma's Claudio Dansky Ullmann as its chief medical officer

Ullmann was most recently the senior vice president and head of clinical development at Infinity Pharmaceuticals Inc, where he oversaw all clinical development and operations


Steuern für Sanofi-Deal bringen Boehringer in rote Zahlen

Steuerzahlungen von mehr als drei Milliarden Euro haben das Pharma-Unternehmen Boehringer Ingelheim im vergangenen Jahr in die roten Zahlen geführt. Unterm Strich fiel ein Verlust von 223 Millione...

Brakes On Sanofi’s Dengvaxia Prospects Amid WHO-SAGE Screening Advice?

WHO’s recommendation around a pre-vaccination screening strategy for Sanofi’s Dengvaxia could potentially dull the prospects of the product further, especially...   

Tuesday 24th April 2018

Takeda strikes deal to buy Shire for $65bn

Japanese company makes its biggest bet to join the top ranks of global pharma groups

As Amgen Looks To Aimovig's Launch, It May Learn From Repatha's Past

Amgen started 2018 off on solid footing with a 2% jump in Q1 revenue to $5.55bn versus consensus estimates of...   

ERYTECH meldet Einreichung des "Document de Référence" 2017 und des Jahresberichts 2017 auf Formblatt 20-F

ERYTECH Pharma (Euronext Paris: ERYP Nasdaq: ERYP), ein Biopharma-Unternehmen, das sich mit der klinischen Phase der Entwicklung innovativer Therapien für schwere Krebsformen und seltene Erkrankun...

CHEK Explodes, ATOS Scripts History, CDMO Working On A Facelift, EYPT In Focus

The following are some of today's top gainers in the pharma/biotech sector.

Pharma’s isolated islands of innovation

With service design and technology often failing the patient, why perspective on improving outcomes need to change

Kaesong Complex A Starting Point For Two Koreas' Healthcare Cooperation?

As political talks gain momentum, the Kaesong Industrial Complex in North Korea could be the starting point of possible healthcare...   

Deal Watch Asia Focus: Pfenex Licenses Asian Rights To Forteo Copy To NT Pharma Group

Otsuka obtains Japanese rights to two cancer gene therapy candidates from Takara. GlaxoSmithKline extends its protein degradation collaboration with Kymera.  

Mylan: Das sieht ansprechend aus!

Mylan ist ein Unternehmen aus den Niederlanden, das auch im Nasdaq 100 geführt wird. Die Aktie entstammt der Branche Pharma, Kosmetik und Gentechnik. Das Unternehmen wiederum dürfte in Deutschland ...

Incyte Corp: Massive Schwankungen! Vorsicht!

Incyte Corp ist ein in Deutschland wenig gehandeltes Unternehmen aus den USA. Die Aktie ist Teil der Branche Pharma/Kosmetik/Gesundheit und dürfte in den kommenden Monaten und Jahren weitere Schwan...

Pharma Q1 Results Preview: Shire, AbbVie, Bristol, Sanofi, Allergan

All eyes are on Shire in its first quarter of reporting separate figures for its neuroscience division as Takeda ramps...   

Adents Announces Diverse Lineup of Prominent Experts for Serialization Innovation Summit, June 20-21 in Philadelphia

Microsoft, Siemens, HDA& GS1 among Impressive Group of Forward-Thinking Speakers to Present Comprehensive Serialization Thought Leadership Adents, a leading provider of premier, versatile serialization and track & trace solutions, has announced a prominent line-up of expert presenters for its Philadelphia Serialization Innovation Summit....

STAT Plus: Supreme Court rules that patent reviews detested by pharma are constitutional

“If you’re an innovator drug company, you’re probably disappointed today.”

Astellas submits NDA for gilteritinib approval in Japan and USA

Japanese drug major Astellas Pharma today announced that, on March 23, it submitted a New Drug Application…

BRIEF—Novartis files for Japanese approval of Kymriah

Swiss pharma giant Novartis says that it has filed its chimeric antigen receptor T cell (CAR-T) therapy…

Sterling Pharma Solutions experiences record US growth

The global contract development and manufacturing organisation has more than doubled its sales in the US in the last two years

Midatech Pharma PLC 2017 Q4 - Results - Earnings Call Slides

Pfizer’s copy of Herceptin held up by FDA

US pharma giant Pfizer has suffered a setback with its development of a biosimilar version of Herceptin…

Catalent To Invest $5 Million at Somerset Site to Create New Drug Development and Modified Release Center of Excellence

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it plans to invest $5 million in the creation of a new drug development center of excellence at its Somerset, New Jersey facility and headquarters. SOMERSET, N.J. (PRWEB) April 24, 2018 Catalent Pharma Solutions, the ...

White Oak Healthcare Finance Provides $30 Million to BRF Hospitals

White Oak Healthcare Finance, LLC (“WOHCF”), today announced it acted as sole lead arranger and administrative agent on the funding of a $30 million senior credit facility to University Health System (“UHS”), a division of Biomedical Research Foundation of Northwest Louisiana (“BRF”). BRF manages the University Health System hospitals, formerly ...

Concept Life Sciences appoints Matilda Bingham as Site Director and David Higton as Biotransformation and Metabolite Identification Expert, at its Alderley Park site

Appointments support expansion of expertise in integrated drug discovery and development Manchester, UK, 24 April 2018: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed Matilda Bingham as Site Director of its Alderley Park site in Cheshire, UK, and David Higton as Principal Scientist (Biotransformat...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks